Peter Blume-Jensen

President and CEO, Director, Acrivon Therapeutics, Inc.

Bought, 12 months

$0.1M

Sold, 12 months

$0.0M

Companies

Latest trade

Aug 25, 2026

Companies

Acrivon Therapeutics, Inc.President and CEO, Director +$0.1M −$0.0M

Trades

ACRV Sold 14,036 shares at $2.21 $0.0M Aug 25

ACRV Bought 49,000 shares at $1.68 $0.1M Jan 14

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.